Tate & Lyle plc (LON:TATE)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 2.47B +8.7% |
| Revenue (ttm) | 2.01B +15.6% |
| Net Income | 97.00M -32.2% |
| EPS | 0.22 -37.1% |
| Shares Out | 442.56M |
| PE Ratio | 25.71 |
| Forward PE | 15.14 |
| Dividend | 0.20 (3.57%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 1,028,956 |
| Open | 555.50 |
| Previous Close | 556.50 |
| Day's Range | 554.50 - 558.00 |
| 52-Week Range | 319.40 - 580.00 |
| Beta | 0.35 |
| Analysts | Hold |
| Price Target | 554.40 (-0.65%) |
| Earnings Date | Nov 5, 2026 |
About Tate & Lyle
Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilize... [Read more]
Financial Performance
In fiscal year 2026, Tate & Lyle's revenue was 2.01 billion, an increase of 15.55% compared to the previous year's 1.74 billion. Earnings were 97.00 million, a decrease of -32.17%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for TATE stock is "Hold." The 12-month stock price target is 554p, which is a decrease of -0.65% from the latest price.
News
Swinney visits 'crisis' Inverclyde towns asking for help after 1,500 job losses
John Swinney is facing calls for government action to support one of Scotland's smallest council areas as it struggles with the cumulative loss of 1,500 jobs. The first minister will spend much of the...
Tate supporters rally for brothers ahead of bail hearing in Miami
Supporters of Andrew and Tristan Tate gathered outside a Miami detention centre ahead of their bail hearing.
Ingredion (INGR) Q2 2026 Earnings Call Transcript
Tate & Lyle acquisition and Argo recovery amid tapioca cost pressures.
Tate brothers are too notorious to be flight risk, lawyers argue
The pair’s legal team want them freed on bail as they fight their removal from US to face rape and sex trafficking charges in UK.
Tate & Lyle downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Damian McNeela downgraded Tate & Lyle to Hold from Buy with an unchanged price target of 595 GBp. The firm cites Ingredion’s firm offer for Tate for…
Tate & Lyle downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Tate & Lyle to Neutral from Outperform with a 595 GBp price target
Tate & Lyle: From sugar barons in London's East End to US takeover
Tate & Lyle on Monday agreed to a £2.7 billion ($3.6 billion) takeover in cash from U.S.-based Ingredion , marking a new chapter for one of Britain's oldest industrial names and creating a global food...
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.
Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle
Creates a scaled global provider of specialty ingredient solutions for a healthier, tastier and more sustainable future of food Broadens Ingredion's specialty ingredients platform across texturants, ...
UK's Tate & Lyle agrees $3.6 billion Ingredion takeover
Britain's Tate & Lyle has agreed to a £2.7 billion ($3.60 billion) offer from U.S. rival Ingredion , the companies said on Monday, creating a food and beverage ingredients major.
Tate & Lyle H2 Earnings Call Highlights
Tate & Lyle LON: TATE said its full-year results were in line with revised guidance, as muted market demand and regional weakness offset progress from the integration of CP Kelco and ongoing productiv...
Tate & Lyle Earnings Call Transcript: H2 2026
Integration of CP Kelco is complete, supporting a broader solutions offering and early signs of top-line momentum. FY results met revised guidance, with revenue and EBITDA down 3% like-for-like, and a GBP 20 million bio-gums headwind expected in FY 2027.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Tate & Lyle Slides: H2 2026
Tate & Lyle has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 21, 2026.
Tate & Lyle Annual report: H2 2026
Tate & Lyle has published its H2 2026 annual report on May 21, 2026.
Ingredion Takeover Target Tate & Lyle Posts Fall in Profit
The British ingredients company reported lower profit for what it called a disappointing fiscal year.
Tate & Lyle downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Tate & Lyle to Hold from Buy with a 547 GBp price target
Ingredion confirms non-binding all-cash offer of 595p/share for Tate & Lyle
In a regulatory filing, Ingredion (INGR) issued a statement regarding a non-binding all-cash offer by the company for Tate & Lyle PLC (TATYY). “Ingredion confirms it has made a non-binding…
Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer
The proposed offer value is a 64% premium to the London-listed food-and-beverage ingredient company's closing share price Wednesday.
Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid
Britain's Tate & Lyle on Thursday said it was in discussions with U.S. rival Ingredion over a possible takeover of the food ingredients maker, valuing it at 2.74 billion pounds ($3.70 billion), ...
Tate & Lyle price target lowered to 375 GBp from 390 GBp at UBS
UBS analyst Priyanka Patel lowered the firm’s price target on Tate & Lyle to 375 GBp from 390 GBp and keeps a Neutral rating on the shares. Published first on…
Tate & Lyle price target lowered to 375 GBp from 399 GBp at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Tate & Lyle to 375 GBp from 399 GBp and keeps an Underweight rating on the shares.
Tate & Lyle price target lowered to 500 GBp from 540 GBp at Citi
Citi lowered the firm’s price target on Tate & Lyle to 500 GBp from 540 GBp and keeps a Buy rating on the shares.
Tate & Lyle Earnings Call Transcript: Q3 2026
Q3 results were in line with expectations, with muted demand leading to a 2% pro forma revenue decline, but reported revenue rose 15% due to the CP Kelco acquisition. Strategic investments and strong customer engagement in innovation and fiber fortification support future growth.
Tate & Lyle Earnings release: Q3 2026
Tate & Lyle released its Q3 2026 earnings on February 26, 2026, summarizing the period's financial results.